Deebie Symmes

COO Cbo and Co-founder @Aluda Pharmaceuticals, Inc

Aluda is a discovery and development company that focuses on fundamental mechanisms with broad clinical potential wihtin the domains of the signaling between and within cells that is central to immunological defense, inflammation and pathogenesis across many disease states. Aluda\'s team has experience in development through clinical phase II and brings specific knowledge of molecular design as well as best practices in discovery, from target validation and optimization to selection of leads and clinical strategies.